V2X (VVX) Q1 2025 Earnings Call Transcript

V2X reported Q1 revenue of $1.02 billion, adjusted EBITDA of $67 million, and adjusted EPS of $0.98, while reaffirming full-year 2025 guidance for $4.4 billion revenue, $313 million adjusted EBITDA, and $4.65 adjusted EPS. The quarter featured several major contract wins totaling hundreds of millions of dollars, backlog at roughly 3x annual revenue, and liquidity of about $650 million, supported by a 50+ bp improvement in debt costs. Management also flagged only 1%-2% of 2025 revenue still exposed to recompete risk and expects over 100% cash conversion for the year.

Analysis

V2X’s quarter is less about the headline beat and more about the sequencing change: a temporarily soft book-to-bill is being intentionally traded for a much cleaner second-half setup. The company has effectively de-risked a large share of 2025 revenue by extending core programs deep into the decade, which should compress investor focus away from near-term contract churn and toward execution on incremental awards and margin mix.

The second-order winner is not just V2X, but the broader “mission support” ecosystem around it: if the company is winning larger, more integrated, fixed-price pursuits, it will pull more work toward subs, specialist integrators, and hardware/services vendors that can scale into multi-domain programs. The flip side is competitive pressure on smaller incumbents that rely on fragmented task-order awards; V2X is signaling it can bundle capability, geography, and security clearance into a single prime offering, which tends to widen the moat over time.

The market may be underestimating how much of the leverage story is now self-funded rather than dependent on operating improvement alone. A 50+ bp refinancing benefit, combined with sequential debt paydown and a cash conversion profile that should turn positive after Q1 working-capital drag, creates room for either accretive M&A or repurchases without stressing the balance sheet. That optionality is valuable because it gives management three ways to win in 2025: organic backlog conversion, capital structure optimization, and inorganic capability extension.

The main risk is timing, not demand: if large awards slip a quarter or two, the stock can de-rate quickly because back-half weighting is doing a lot of the heavy lifting. The contrarian read is that the market may be over-fixated on the weak current-quarter cash flow and underappreciating that Q1 is the funding trough before WTRS/F5/other ramp items hit; if those awards stay on schedule, the setup into late 2025 is materially better than the current print suggests.

Key Decisions for Investors

• Long VVX for a 3-6 month horizon: use weakness around any post-earnings digestion to build a position; the risk/reward favors upside if backlog converts and second-half ramps arrive on schedule, with downside cushioned by extended program visibility and improving interest expense.
• Pair trade: long VVX / short a smaller defense services peer with heavier recompete exposure and less geographic diversification; thesis is that V2X’s 'recompete holiday' and larger fixed-price pipeline should support relative multiple expansion over the next 2 quarters.
• Buy VVX Jan-2026 calls or call spreads to express the back-half re-rating without paying full equity downside; best if you expect incremental award announcements and guidance-credibility reacceleration into Q3/Q4.
• If already long, sell covered calls against the position into strength above the recent post-call range; the stock likely trades on award timing, so premium capture makes sense while waiting for backlog recognition.
• Avoid shorting on Q1 cash flow alone; the better catalyst to fade would be a visible slip in award cadence or backlog conversion, not the current quarter's working-capital use.